News & updates

Why researchers pursue an international career

Created on:


October 19, 2021

The curiosity and enthusiasm about a specific topic can drive scientists halfway across the world. Joana Brás Gomes Nunes’ interest in cell metabolism brought her via Portugal and the United States to Leiden. And she is certainly not the only one: The LUMC has researchers from over 70 different countries employed. What drives them, and what is the advantage of such an international career?

Joana Brás Gomes Nunes, originally from Portugal, has been researching cellular energy management and metabolism for more than ten years. In those years, she has lived and worked in three different countries. Her international ambitions were already fueled during her studies, when she left for Spain. “There I realized how much I loved going abroad, broadening my horizon and getting to know new realities.” 

International environment

And she is certainly not the only one. “Research groups are becoming more and more international. As an example, I’ve worked in a lab consisting of researchers from 14 different countries.” Joana thinks that one important reason for this is that valuable international collaborations are crucial for impactful research, and that is what pushes researchers to move. In addition, an international environment has many advantages. “In international research groups, there is a higher diversity in ways of thinking and skills which result in discussion and exchange of knowledge, and that is what drives science. On the other hand, it is also a good way to improve your English. Last but not least: it is a lot of fun!”

Read the rest of the article here! 


More news & updates

AE-TBC wins EDCTP’s Outstanding Research Team 2020 prize!

November 2, 2021

The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.

A packed Amia Conference Room

Semantic Technology to Ensure FAIR patient Data in Africa

November 14, 2023

LUMC and LUMC Global was represented at the 2023 Conference of the American Medical Informatics Association which opened on 12 November. Prof. Mirjam van Reisen, Prof FAIR Data Science and Erik Schultes, presented at the scientific panel on “The CEDAR Workbench: Semantic Technology to Ensure FAIR Data” alongside Mark A. Musen, M.D. from the Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford; Anthony L. Juehne, from the Office of the Director, National Institutes of Health, Bethesda; and  Rachel L. Richesson, University of Michigan Medical School, Ann Arbor.

The presentations focused on the LUMC-research on the curation of medical data to ensure data is Findable, Accessible (under well-defined conditions), Interoperable and Reusable (FAIR) and Federated AI Ready.

Background Image Of A Scientist Recording Test Results In A Lab

Janssen COVID-19 vaccine approved for use in EU on March 11

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

Stay up to date with news, inspirations and events.

© LUMC Global. All rights reserved. Website door philogirl

Contact

Social